A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy (Q33797499)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy |
scientific article |
Statements
1 reference
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy (English)
1 reference
Richard F Kefford
1 reference
Philip R Clingan
1 reference
Benjamin Brady
1 reference
Andrea Ballmer
1 reference
Adele Morganti
1 reference
Peter Hersey
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference